Company profile

Westlake Genetech. Ltd. is an innovative biotech company. By building AI-driven gene therapy platforms and developing differentiated self-developed gene therapy products, the company is committed to advancing the full-process implementation of AI-powered gene therapy.

GOAL

The company has assembled an interdisciplinary team covering genomics, deep learning, bioinformatics, molecular biology, cell biology and immunology, with PhD and master's holders accounting for 70% of its workforce. The company provides comprehensive support for internal R&D, and has built a 1,149 ㎡ GMP facility for cell and gene therapy, facilitating clinical translation of its research programs.

SUPPORT

The company's proprietary AI-powered full-value-chain gene therapy platform has produced a large number of non-liver-targeted AAV capsids and developed proprietary gene editing tools. Leveraging these advances, the company develops safe and accessible innovative gene therapies for rare diseases, oncology and other unmet medical indications.

HIGHLIGHT

Scientific founder

leader

Lijia Ma, PhD

Founder & Board Member, Westlake Genetech. Ltd.

Lead Scientist, Changping Laboratory

Dr. Ma has an interdisciplinary background in bioinformatics, molecular biology and basic medicine, with long-term dedication to developing cutting-edge cell and gene therapy technologies and innovative therapeutic products.

She was previously an Assistant Professor at the School of Life Sciences, Westlake University. Earlier in her career, she headed multiple large-scale genomics research projects at the NIH and BGI.

She has authored over 30 highly cited publications in preeminent journals, including Nature, Science and Nature Structural & Molecular Biology.


News

瑞鸥科学创新联盟首批研究者成员公布:https://mp.weixin.qq.com/s/KLFoN0rdNNZRuhcF-sBIlA

高榕榕汇AIGC系列·走进谷歌主题分享:
https://mp.weixin.qq.com/s/D5qGY-zaBxfJYbDZJ2YS3A

Company vision

We are committed to mapping the full-process implementation of AI-powered Gene Therapy.

Company culture
Exploration

We explore and delve into cutting-edge life sciences and technologies, leveraging AI to empower gene therapy.


Innovation

We adhere to innovation and push forward technology research and drug development with new methods and strategies.


Mission

We take on our mission, focus on the field of cell and gene therapy, and serve the cause of human health.


Excellence

We pursue excellence and forge ahead on the road of striving to be a leading pharmaceutical company in the world.